1,128
Views
105
CrossRef citations to date
0
Altmetric
Review Article

A review of the electrophilic reaction chemistry involved in covalent DNA binding

&
Pages 728-748 | Received 03 Mar 2010, Accepted 14 May 2010, Published online: 20 Aug 2010

References

  • Andrews LE, Bonin AM, Fransson LE, Gillson A-ME Glover, SA. (2006). The role of steric effects in the direct mutagenicity of N-acyloxy-N-alkoxyamides. Mutat Res 605:51–62.
  • Aptula AO, Enoch SJ, Roberts DW. (2009). Chemical mechanisms for skin sensitisation by aromatic compounds with hydroxy and amino groups. Chem Res Toxicol 22:1541–1547.
  • Aptula AO, Patlewicz G, Roberts DW. (2005). Skin sensitization: Reaction mechanistic applicability domains for structure-activity relationships. Chem Res Toxicol 18:1420–1426.
  • Aptula AO, Roberts DW. (2006). Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: General principles and application to reactive toxicity. Chem Res Toxicol 19:1097–1105.
  • Arlt VM, Sorg BL, Osborne M, et al. (2003). DNA adduct formation by the ubiquitous environmental pollutant 3-nitrobenzanthrone and its metabolites in rats. Biochem Biophys Res Commun 300:107–114.
  • Arya DP, Jebaratnam J. (1995). DNA cleaving ability of 9-diazofluorenes and diaryl diazomethanes: Implications for the mode of action of the kinamycin antibiotics. J Org Chem 60:3268–3269.
  • Ashby J. (1986). The prospects for a simplified and internationally harmonised approach to the detection of possible human carcinogens and mutagens. Mutagen 1:3–16.
  • Ashby J, Richardson CR, Lefevre PA, Callander RD, Styles JA. (1985). Chloracetamide-N-metholol: An example of an in vitro and in vivo clastogen which is non-mutagenic to Salmonella. Mutat Res 156:19–32.
  • Ashby J, Tennant RW. (1988). Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat Res 204:17–115.
  • Ashby J, Tennant RW. (1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemical tested by the US NTP. Mutat Res 257:229–306.
  • Banks TM, Bonin AM, Glover SA, Prakash AS. (2003). Mutagenicity and DNA damage studies of N-acyloxy-N-alkoxyamides—The role of electrophilic nitrogen. Org Biomol Chem 1:2238–2246.
  • Beaumont KC, Causey AG, Coates PE, Smith DA. (1996). Pharmacokinetics and metabolism of zamifenacin in mouse, rat, dog and man. Xenobiotica 26:459–471.
  • Bedir A, Aliyazicioglu Y, Bilgici B, et al. (2008). Assessment of genotoxicity in rats treated with the antiabetic agent, pioglitazone. Environ Mol Mutagen 49:185–191.
  • Benigni R, Bossa C. (2008). Structure alerts for carcinogenicity, and the Salmonella assay system: A novel insight through the chemical relational databases technology. Mutat Res 659:248–261.
  • Benigni R, Conti L, Crebelli R, Rodomonte A, Vari MR. (2005). Simple and α,β-unsaturated aldehdyes: Correct prediction of genotoxic activity through structure-activity relationship models. Environ Mol Mutagen 46:268–280.
  • Benigni R, Giuliani A, Franke R, Gruska A. (2000). Quantitative structure-activity relationships of mutagenic and carcinogenic aromatic amines. Chem Rev 100:3697–3714.
  • Benigni R, Giuliani A, Gruska A, Franke R. (2003). QSARs for the mutagenicity and carcinogenicity of the aromatic amines. In: Benigni R, ed. Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens. Boca Raton, FL: CRC Press.
  • Benigni R, Netzeva TI, Benfenati E, et al. (2007). The expanding role of predictive toxicology: An update on the (Q)SAR models for mutagens and carcinogens. J Environ Sci Health C 25:53–97.
  • Beyerbach A, Farmer PB, Sabbioni G. (2006). Biomarkers for isocyanate exposure: Synthesis of isocyanate DNA adducts. Chem Res Toxicol 19:1611–1618.
  • Bieler CA, Arlt VM, Wiessler M, Schmeiser HH. (2003). DNA adduct formation by the environmental contaminant 3-nitrobenzanthrone in V79 cells expressing human cytochrome P450 enzymes. Can Letts 200:9–18.
  • Boberg EW, Miller EC, Miller JA, Poland A, Liem A. (1983). Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver. Cancer Res 43:5163–5173.
  • Bolton JL, Thatcher GRJ. (2008). Potential mechanisms of estrogen quinone carcinogenesis. Chem Res Toxicol 21:93–101.
  • Bonin AM, Banks TM, Campbell JJ, et al. (2001). Mutagenicity of electrophilic N-acyloxy-N-alkoxyamides. Mutat Res 494:115–134.
  • Borchert P, Wislocki PG, Miller JA, Miller EC. (1973). The metabolism of the naturally occuring hepatocarcinogen safrole to 1'-hydroxysafrole and the electrophilic reactivity of 1'-acetoxysafrole. Can Res 33:575–589.
  • Casalegno M, Sello G, Benfenati E. (2008). Definition and detection of outliers in chemical space. J Chem Inf Model 48:1592–1601.
  • Cheng G, Shi Y, Sturla SJ, et al. (2003). Reaction of formaldehyde plus acetaldehyde with deoxyguanosine and DNA: Formation of cyclic deoxyquanosine adducts and formaldehyde cross-links. Chem Res Toxicol 16:145–152.
  • Comber M, Simpson B. (2007). Grouping of petroleum substances. EUR report no 22481 EN. Available at ECB Web site: http://ecb.jrc.it/qsar/background/index.php?c=CAT Accessed ‘1st March 2010’.
  • Cooper MT, Porter TD. (2000). Mutagenicity of nitrosamines in methyltransferase-deficient strains of Salmona typhimurium coexpressing human cytochrome P450 2E1 and reductase. Mutat Res 454:45–52.
  • Cronin MTD, Garrod JF, Balls M. (2008). Development of integrated testing strategies for REACH: Motivation, background and introduction. ATLA 36:i–iii.
  • Desler C, Johannessen C, Rasmusen LJ. (2009). Repair of DNA damage induced by anthanthrene, a polycyclic aromatic hydrocarbon (PAH) without bay or fjord regions. Chem Biol Interact 177:212–217.
  • Diderich B. (2010). Tools for category formation and read-across. Overview of the OECD (Q)SAR Application Toolbox. In: Cronin MTD, Madden JC, eds. In Silico Toxicology: Principles and Applications. Cambridge, UK: Royal Society of Chemistry.
  • Dogliotti E. (2006). Molecular mechanisms of carcinogenesis by vinyl chloride. Annali dell'Istituto superiore di sanità 42:163–169.
  • Dorado L, Montoya MR, Mellado JMR. (1992). A contribution to the study of the structure-mutagenicity relationship for α-dicarbonyl compounds using the Ames test. Mutat Res 269:301–306.
  • DSSTox. (2009). Carinogenicity potency database. Available at: http://www.epa.gov/ncct/dsstox.index.html.
  • EC. (2003). Commission of the European Communities. 2003. Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Off J Eur Union L 66/26–L 33/35 of 11.3.2003.
  • EC. (2006). Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No. 793/93 and Commission Regulation (EC) No. 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC, and 2000/21/EC. Off J Eur Union L 396/1 of 30.12.2006.
  • EC. (2007). REACH technical guidance. Available at: http://ecb.jrc.it/reach/rip/.
  • ECHA. (2008) Guidance on information requirements and chemical safety assessment Chapter R.6: QSARs and grouping of chemicals. Available at: http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_r6_en.pdf?vers=20_08_08.
  • Ellison CM, Enoch SJ, Cronin MTD, Madden JC, Judson P. (2009). Definition of the applicability domains of knowledge-based predictive toxicology expert systems by using a structural fragment-based approach. ATLA 37:533–545.
  • Enoch SJ, Cronin MTD, Madden JC, Hewitt M. (2009a). Formation of structural categories to allow for read-across for teratogenicity. QSAR Comb Sci 28:696–708.
  • Enoch SJ, Cronin MTD, Schultz TW, Madden JC. (2008). Quantitative and mechanistic read across for predicting the skin sensitisation potential of alkenes acting via Michael addition. Chem Res Toxicol 21:513–520.
  • Enoch SJ, Roberts DW, Cronin MTD. (2009b). Electrophilic reaction chemistry of low molecular weight respiratory sensitisers. Chem res Toxicol 22:1447–1453.
  • Fabjan E, Hulzebos E, Mennes W, Piersma AH. (2006). A category approach for reproductive effects of phthalates. Crit Rev Toxicol 36:695–726.
  • FitzGerald BE, Shank RC. (1996). Methylation status of DNA cystosine during the course of induction of liver cancer in hmasters by hydrazine sulfate. Carcinogenesis 17:2703–2709.
  • Floyd RA. (1990). Role of oxygen free-radicals in carcinogenesis and brain ischemia. FASEB J 4:2587–2597.
  • Fu PP. (1990). Metabolism of nitro-polycyclic aromatic hydrocarbons. Drug Metab Revs 22:209–268.
  • Fu PP, Xia Q, Lin G, Chou MW. (2004). Pyrrolizidine alkaloids—Genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Revs 36:1–55.
  • Gaikwad NW, Bodell WJ. (2001). Formation of DNA adducts by microsomal and peroxidase activation of p-cresol: Role of quinone methide in DNA adduct formation. Chem Biol Interact 138:217–229.
  • Gaikwad NW, Bodell WJ. (2003). Formation of DNA adducts in HL-60 cells treated with the toluene metabolite p-cresol: A potential biomarker for toluene exposure. Chem Biol Interact 145:149–158.
  • Garcia CL, Mechilli M, De Santis LP, Schinoppi A, Kobos K, Palitti F. (2009). Relationship between DNA lesions, DNA repair and chromosoma; damage induced by acetaldehyde. Mutat Res 662:3–9.
  • Gerberick GF, Ryan CA, Kern PS, et al. (2005). Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis 16:157–202.
  • Gomez-Bombarelli R, Gonzalez-Perez M, Perez-Prior MT, Manso JA, Calle E, Casado J. (2008). Chemical reactivity and biological activity of diketene. Chem Res Toxicol 21:1964–1969.
  • Granville CA, Ross MK, Tornero-Velez R, et al. (2005). Genotoxicity and metabolism of the source-water contaminant 1,1-dichloropropene: Activation by GSTT1-1 and structure-activity considerations. Mutat Res 572:98–112.
  • Guengerich FP, Parikh A, Johnson EF, et al. (1997). Heterologous expression of human drug-metabolising enzymes. Drug Metab Dispos 25:1234–1241.
  • Hayashi M, Kamata E, Hirose A, Takahashi M, Morita T, Ema M. (2005). In silico assessment of chemical mutegenesis in comparison with results of Salmonella microsome assay on 909 chemicals. Mutat Res 588:129–135.
  • Helma C. (2006). Lazy structure-activity relationships (lazar) for the prediction of rodent carcinogenicity and Salmonella mutagenicity. Mol Divers 10:147–158.
  • Hemminki K. (1981). Reactions of β-propiolactone, β-butyrolactone and γ-butyrolactone with nucleic acids. Chem Biol Interact 34:323–331.
  • Ishihama M, Toyooka T, Ibuki Y. (2008). Generation of phosphorylated histone H2AX by benzene metabolites. Toxicol In Vitro 22:1861–1868.
  • ISSCAN. (2009). ISSCAN database. Available at: http://www.iss.it/ampp/dati/cont.php%3Fid=233%26lang=1%26tipo=7.
  • Jones CR, Sabbioni G. (2003). Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes. Chem Res Toxicol 16:1251–1263.
  • JRC. (2009). ToxTree. Available at: http://ecb.jrc.ec.europa.eu/qsar/qsar-tools/index.php?c=TOXTREE.
  • Kalgutkar AS, Dalvie DK, O’Donnell JP, Taylor TJ, Sahakian DC. (2002). On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics. Curr Drug Metab 3:379–424.
  • Kalgutkar AS, Gardner I, Obach RS, et al. (2005). A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 6:161–225.
  • Kalgutkar AS, Soglia JR. (2005). Minimising the potentail for metabolic activation in drug discovery. Expert Opin Drug Metab Toxicol 1:91–142.
  • Kazius J, McGuire R, Bursi R. (2005). Derivation and validation of toxicophores for mutagenicity prediction. J Med Chem 48:312–320.
  • Kazius J, Nijssen S, Kok J, Back T, IJzerman AP. (2006). Substructure mining using elaborate chemical representation. J Chem Inf Model 46:597–605.
  • Kellert M, Brink A, Richter I, Schlatter J, Lutz WK. (2008). Tests for genotoxicity and mutagenicity of furan and its metabolite cis-2-butene-1,4-dial in L5178Y tk+/− mouse lymphoma cells. Mutat Res 657:127–132.
  • Kier LD, Brusick DJ, Auletta AE, et al. (1986). The Salmonella typhimurium/mammalian microsome assay. Mutat Res 168:69–240.
  • Klopman G. (1992). MultiCASE 1. A hierarchical computer automated structure evaluation program. Quant Struct-Act Relat 11:176–184.
  • Klopman G, Chakravarti SK, Harris N, Ivanov J, Saiakhov RD. (2003). In-silico screening screening of high production volume chemicals for mutagenicity using the MCASE QSAR expert system. SAR QSAR Environ Res 14:165–180.
  • Klopman G, Frierson MR, Rosenkranz HS. (1990). The structural basis of the mutagenicity of chemicals in Salmonella typhimurium: The Gene-Tox data base. Mutat Res 228:1–50.
  • Klopman G, Rosenkranz HS. (1994). Approaches to SAR in carcinogenesis and mutagenesis—Prediction of carcinogenicity/mutagenicity using MULTI-CASE. Mutat Res 305:33–46.
  • Kroeger-Koepke MB, Smith RH, Goodnow EA, et al. (1991). 1,3-Dialkyltriazenes: Reactive intermediates and DNA alkylation. Chem Res Toxicol 4:334–340.
  • Kuhne R, Ebert R-U, Schuurmann G. (2006). Model selection based on structural similarity—Method description and application to water solubility prediction. J Chem Inf Model 46:636–641.
  • Kuhne R, Ebert R-U, Schuurmann G. (2009). Chemical domain of QSAR models from atom-centered fragments. J Chem Inf Model 49:2660–2669.
  • Lake BG. (1999). Coumarin metabolism, toxicity and carcinogenicity: Relevance for human risk assessment. Food Chem Toxicol 37:423–453.
  • Lambert CE, Shank RC. (1988). Role of formaldehdye hydrazone and catalase in hydrazine-induced methylation of DNA quanine. Carcinogenesis 9:65–70.
  • Laufer RS, Dmitrienko GI. (2002). Diazo group electrophilicity in kinamycins and lomaiviticin A: Potential insights into the molecular mechanism of antibacterial and antitumour activity. J Am Chem Soc 124:1854–1855.
  • McGregor D. (2007). Hydroquinone: An evaluation of the human risks from its carcinogenic and mutagenic properties. Crit Rev Toxicol 37:887–914.
  • Mekenyan O, Dimitrov S, Serafimova R, et al. (2004a). Identification of the structural requirements for mutagenicity by incorporating molecular flexibility and metabolic activation of chemicals I: TA100 Model. Chem Res Toxicol 17:753–766.
  • Mekenyan O, Todorov M, Serafimova R, et al. (2007). Identifying the structural requirements for chromosomal aberration by incorporating molecular flexibility and metabolic activation of chemicals. Chem Res Toxicol 20:1927–1941.
  • Mekenyan OG, Dimitrov SD, Pavlov TS, Veith GD. (2004b). A systematic approach to simulating metabolism in computational toxicology. I. The TIMES heuristic modelling framework. Curr Pharm Des 10:1273–1293.
  • Mellado JMR, Montoya MR. (1994). Correlations between chemical reactivity and mutagenic activity against S. typhimurium TA100 for α-dicarbonyl compounds as a proof of the mutagenic mechanism. Mutat Res 304:261–264.
  • Miller EC, Miller JA. (1981). Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 47:2327–2345.
  • Miller JA, Miller EC. (1977). Ultimate chemical carcinogens as reactive mutagenic electrophiles. In: Hiatt HH, Watson JD, Winsten JA, eds. Origins of Human Cancer. Cold Spring Habor, NY: Cold Spring Harbor Laboratory, 605–628.
  • Mizutani T, Yoshida K, Kawazoe S. (1994). Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Drug Metab Dispos 22:750–755.
  • Moller P, Wallin H. (2000). Genotoxic hazards of azo pigments and other colorants related to 1-phenylazo-2-hydroxynaphthalene. Mutat Res 462:13–30.
  • Mosier PD, Jurs PC, Custer LL, Durham SK, Pearl GM. (2003). Predicting the genotoxicity of thiophene derivatives from molecular structure. Chem Res Toxicol 16:721–732.
  • Mutlib AE, Dickenson P, Chen SY, Espina RJ, Daniels JS, Gan LS. (2002). Bioactivation of benzylamine to reactive intermediates in rodents: Formation of glutathione, glutamate, and peptide conjugates. Chem Res Toxicol 15:1190–1207.
  • Noll DM, Mason TM, Miller PS. (2006). Formation and repair of interstrand cross-links in DNA. Chem Rev 106:277–301.
  • OECD. (2004). The Report from the Expert Group on (Quantitative) Structure-Activity Relationship ([Q]SARs) on the Principles for the Validation of (Q)SARs. OECD Series on Testing and Assessment No. 49. ENV/JM/MONO(2004)/24.
  • OECD. (2007). Guidance on Grouping of Chemicals. Available at: http://www.oecd.org/LongAbstract/0,3425,en_2649_34379_39404999_119829_1_1_37407,00.html.
  • OECD. (2009). The OECD (Q)SAR Application Toolbox. Available at: http://www.oecd.org/document/23/0,3343,en_2649_34379_33957015_1_1_1_1,00.html.
  • Olah GA. (1972). The general concept and structure of carbocations based on differentation of trivalent (“classical”) carbenium ions from three centre bound penta- or tetracoordinated (“nonclassical”) carbonium ions. The role of carbocations in electrophilic reactions. J Am Chem Soc 94:808–820.
  • Osterman-Golkar S, Wachtmeister CA. (1976). On the reaction kinetics in water of 1,3-propane sultone and 1,4-butane sultone: A comparison of reaction rates and mutagenic activities of some alkylating agents. Chem Biol Interact 14:195–202.
  • Passerini L. (2003). QSARs for individual classes of chemical mutagens and carcinogens. In: Benigni R, ed. Quantitative Structure-Activity Rleationships (QSAR) Models of Mutagens and Carcinogens. Boca Raton, FL: CRC Press.
  • Peterson LA. (2006). Electrophilic intermediates produced by bioactivation of furan. Drug Metab Rev 38:615–626.
  • Pound AW, Franke F, Lawson TA. (1976). The binding of ethyl carbamate to DNA of mouse liver in vivo: The nature of the bound molecule and the site of binding. Chem Biol Interact 14:149–163.
  • Pound AW, Lawson TA. (1978). Carcinogenesis by carbamic acid esters and their binding to DNA. Can Res 36:1101–1107.
  • Preussmann R, Hodenberg AV. (1970). Mechanism of carcinogenesis with 1-aryl-3,3-dialkyltriazenes—II: In vitro-alkylation of guanosine, RNA and DNA with aryl-monoalkyltriazines to form 7-alkylguanine. Biochem Pharmacol 19:1505–1508.
  • Randerath K, Haglund RE, Phillips DH, Reddy MV. (1984). 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice. Carcinogenesis 5:1613–1622.
  • Rannug U, Gothe R, Wachtmeister CA. (1976). The mutagenicity of chloroethylene oxide, chloro-acetaldehdye, 2-chloroethanol and chloroacetic acid, conceivable metabolites of vinyl chloride. Chem Biol Interact 12:251–263.
  • Regal KA, Laws GM, Yuan C, Yost GS, Skiles GL. (2001). Detection and characterisation of DNA adducts of 3-methylindole. Chem Res Toxicol 14:1014–1024.
  • Roberts DW, Aptula AO, Cronin MTD, Hulzebos E, Patlewicz G. (2007a). Global (Q)SARs for skin sensitisation—Assessment against OECD principles. SAR QSAR Environ Res 18:343–365.
  • Roberts DW, Patlewicz G, Kern PS, et al. (2007b). Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. Chem Res Toxicol 20:1019–1030.
  • Roberts DW, Schultz TW, Wolf EM, Aptula AO. (2010). Experimental reactivity parameters for toxicity modelling: Application to the acute aquatic toxicity of SN2 electrophiles to Tetrahymena pyriformis. Chem Res Toxicol 23:228–234.
  • Rosenkranz HS, Klopman G. (1990). The structural basis of the mutagenicity of chemicals in Salmonella typhimurium: The National Toxicology Program Data Base. Mutat Res 228:51–80.
  • Russom CL, Bradbury SP, Broderius SJ. (1997). Predicting modes of toxic action from chemical structure: Acute toxicity in the fathead minnow (Pimephales promelas). Environ Toxicol Chem 16:948–967.
  • Saeed M, Higgenbotham S, Rogan E, Cavelieri E. (2007). Formation of depurinating N3 adenine and N7 quanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA implications for the mechanism of tumor initiation by naphthalene. Chem Biol Interact 165:175–188.
  • Saghir SA, Rick DL, McClymont EL, Zhang F, Bartels MJ, Bus JS. (2009). Mechanism of ethylbenzene-induced mouse-specific lung tumor: Metabolism of ethylbenzene by rat, mouse, and human liver and lung microsomes. Toxicol Sci 107:352–366.
  • Sawatari K, Nakanishi Y, Matsushima T. (2001). Relationships between chemical structures and mutagenicity: A preliminary survey for a database of mutagenicity test results of new work place chemicals. Ind Health 39:341–345.
  • Schaafsma G, Kroese ED, Tielemans ELJP, Van de Sandt JJM, Van Leeuwen CJ. (2009). REACH, non-testing approaches and the urgent need for a change in mind set. Regul Toxicol Pharmacol 53:70–80.
  • Schultz TW. (2010). Adverse outcome pathways: A way of linking chemical structure to in vivo toxicological hazards. In: Cronin MTD, Madden JC, eds. In silico Toxicology: Principles and Applications. Cambridge, UK: Royal Society of Chemistry.
  • Schultz TW, Carlson RE, Cronin MTD, et al. (2006). A conceptual framework for predicting the toxicity of reactive chemicals: Modeling soft electrophilicity. SAR QSAR Environ Res 17:413–428.
  • Schultz TW, Ralston KE, Roberts DW, Veith GD, Aptula AO. (2007). Structure-activity relationships for abiotic thiol reactivity and aquatic toxicity of halo-substituted carbonyl compounds. SAR QSAR Environ Res 18:21–29.
  • Schultz TW, Rogers K, Aptula AO. (2009). Read-across to rank skin sensitisation potential: Subcategories for the Michael acceptor domain. Contact Dermatitis 60:21–31.
  • Sedgwick B. (1992). Oxidation of methylhydrazines to mutagenic methylating derivatives and inducers of the adaptive response to Escherichia coli to alkylation damage. Cancer Res 52:3693–3697.
  • Segal A, Solomon JJ, Mate U, Van Duuren BL. (1982). Formation of 6-dimethylcarbamyloxy-dGuo, 6-dimethylamino-dGuo and 4-dimethylamino-dThd following in vitro reaction of dimethylcarbamyl chloride with calf thymus DNA and 6-diethylcarbamyloxy-dGuo following in vitro reaction of diethylcarbamyl chloride with calf thymus DNA. Chem Biol Interact 40:209–231.
  • Serafimova R, Todorov M, Pavolo T, et al. (2007). Identification of the structural requirements for mutagencitiy, by incorporating molecular flexibility and metabolic activation of chemicals. II. General Ames mutagenicity model. Chem Res Toxicol 20:662–676.
  • Schuphan I, Ebing W. (1978). Metabolism and balance studies of [14C] monolinuron after use in spinach followed by cress and potato cultures. Pestic Biochem Physiol 9:107–118.
  • Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell FR. (1995). Sulfur mustard—Its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 32:765–776.
  • Sobol Z, Engel ME, Rubitski E, Ku WW, Aubrecht J, Schiestl RH. (2007). Genotoxicity profiles of common alkyl halides and esters with alkylating activity. Mutat Res 633:80–94.
  • Stack DE, Li G, Hill A, Hoffman N. (2008). Mechanistic insights into the Michael addition of deoxyquanosine to catechol estrogen-3,4-quinones. Chem Res Toxicol 21:1415–1425.
  • Stein S, Lao Y, Yang I-Y Hecht, SS, Moriya M. (2006). Genotoxicity of acetaldehyde- and crotonaldehyde-induced 1,N2-propanodeoxyguanosine DNA adducts in human cells. Mutat Res 608:1–7.
  • Swenson DH, Lawley PD. (1978). Alkylation of deoxyribonucleic acid by carcinogens dimethyl sulphate, ethyl methanesulphonate, N-ethyl-N-nitrosourea and N-methyl-N-nitrosourea. Biochem J 171:575–587.
  • Tennant RW, Ashby J. (1991). Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a furethr 39 chemicals tested for carcinogenicity by the U.S. National Toxicology Program. Mutat Res 257:209–227.
  • Thompson CM, Subramaniam RP, Grafstrom RC. (2008). Mechanistic and dose considerations for supporting adverse pulmonary physiology in response to formaldehyde. Toxicol Appl Pharmacol 233:355–359.
  • Thompson DC, Perera K, Krol ES, Bolton JL. (1995). o-Methoxy-4-alkylphenols that form quinone methides of intermediate reactivity are the most toxic in rat liver slices. Chem Res Toxicol 8:323–327.
  • US EPA. (2009) Chemical categories report. Available at: http://www.epa.gov/opptintr/newchems/pubs/chemcat.htm.
  • van der Jagt K, Munn S, Torslov J, de Bruijn J. (2004). Alternatives approaches can reduce the use of test animals under REACH. Available at: http://ecb.jrc.ec.europa.eu/documents/REACH/PUBLICATIONS).
  • van Duuren BL. (1988). Direct-acting alkylating and acylating agents—DNA adduct formation, structure-activity, and carcinogenesis. Ann N Y Acad Sci 534:620–634.
  • van Leeuwen K, Schultz TW, Henry T, Diderich B, Veith GD. (2009). Using chemical categories to fill data gaps in hazard assessment. SAR QSAR Environ Res 20:207–220.
  • Verhaar HJM, van Leeuwen CJ, Hermens JLM. (1992). Classifying environmental pollutants. 1: Structure-activity relationships for prediction of aquatic toxicity. Chemosphere 25:471–491.
  • Vonk JA, Benigni R, Hewitt M, et al. (2009). The use of mechanisms and modes of toxic action in integrated testing strategies. The report and recommendations of a workshop held as part of the European Union OSIRIS integrated project. ATLA 37:557–571.
  • Walker JD, Printup H. (2008). Structure-activity relationships for aldehyde categories. QSAR Comb Sci 27:475–482.
  • Wang HT, Zhang S, Tang MS. (2009). Mutagenicity and sequence specificity of acrolein-DNA adducts. Chem Res Toxicol 22:511–517.
  • Wang M, Lao Y, Cheng G, Shi Y, Villalta PW, Hecht SS. (2007). Identification of adducts formed in the reaction of α-acetoxy-N-nitrosopyrrolidine with deoxyribonucleosides and DNA. Chem Res Toxicol 20:625–633.
  • Wang PG, Xian M, Tang X, et al. (2002). Nitric oxide donors: Chemical activities and biological applications. Chem Rev 102:1091–1134.
  • Weinert EE, Dondi R, Colloredo-Melz S, et al. (2006). Substituents on quinone methides strongly modulate formation and stability of their nucleophilic adducts. J Am Chem Soc 128:11940–11947.
  • Wild D, King MT, Gocke E, Eckhardt K. (1983). Study of artificial flavouring substances for mutagenicity in the Slamonella/microsome, BASC and micronucleus tests. Food Chem Toxicol 21:707–719.
  • Wiseman H, Halliwell B. (1996). Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 313:17–29.
  • Woo Y-T Lai, DY. (2003). Mechanisms of action of chemical carcinogens and their role in structure-activity relationships (SAR) analysis and risk assessment. In: Benigni R, ed. Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens. Baco Raton, FL: CRC Press.
  • Xue W, Warshawsky D. (2005). Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A review. Toxicol Appl Pharmacol 206:73–93.
  • Zhou Q, Xu T, Mangrum JB. (2007). Selective N1-alkylation of 2-deoxyguanosine with a quinolinyl quinone methide. Chem Res Toxicol 20:1069–1074.
  • Ziegler-Skylakaakis K, Nill S, Pan, JF, et al. (1998). S-oxygenation of thiourea results in the formation of genotoxic products. Environ Mol Mutagen 31:362–373.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.